Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Eupraxia Pharmaceuticals prices $70 million public offering at $5.50 per share
-
Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares
-
Eupraxia Pharmaceuticals announces proposed public offering of common shares
-
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
-
Ramaswamy-backed Strive to buy Semler in $1.3 billion deal all stock deal, boosting Bitcoin holdings
-
Strive agrees to acquire Semler Scientific in all-stock deal
-
Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction
-
SunPower to acquire Sunder Energy for $40M cash plus shares
-
SPWR to Acquire Sunder Energy to Gain U.S. No. 5 Spot
-
Cantor Fitzgerald Starts CytomX Therapeutics (CTMX) at Overweight
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Pharmaceuticals (RCKT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
Cantor Fitzgerald Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)
-
Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)
-
Cantor Fitzgerald Reiterates Overweight Rating on uniQure BV (QURE)
-
Cantor Fitzgerald Reiterates Overweight Rating on Avita Medical Ltd. (RCEL)
-
Cantor Fitzgerald Reiterates Overweight Rating on Nano-X Imaging (NNOX)
-
Zenith Securities Rising: New Ownership Launches Next Chapter for Institutional Investment Bank
-
Brera Holdings secures $300 million funding to transform into Solana treasury
-
Wall Street Finds Its Solmate: Brera Holdings PLC (NASDAQ: BREA) Announces Oversubscribed $300 Million Private Placement to Fund Establishment of Solana Digital Asset Treasury Backed by Ark Invest and
-
Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
-
Cantor Fitzgerald Reiterates Overweight Rating on Arvinas Inc. (ARVN)
-
CrowdStrike Holdings (CRWD) PT Raised to $500 at Cantor Fitzgerald
-
monday.com Ltd. (MNDY) PT Lowered to $257 at Cantor Fitzgerald
-
Bullish (BLSH) PT Raised to $59 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on MongoDB (MDB)
-
Cantor Fitzgerald Reiterates Neutral Rating on Zoom Video (ZM)
-
Form 424B3 Cantor Fitzgerald Income
-
Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
-
Cantor Fitzgerald Reiterates Overweight Rating on Metsera Inc (MTSR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Structure Therapeutics (GPCR)
-
Cantor Fitzgerald Reiterates Overweight Rating on DoorDash Inc. (DASH)
-
Cantor Fitzgerald Reiterates Overweight Rating on Meta Platforms Inc. (META)
-
Cantor Fitzgerald Reiterates Overweight Rating on Workday (WDAY)
-
Forward Industries launches $4 billion share offering program
-
Forward Industries Announces $4 Billion At-The-Market Equity Offering Program
-
Cantor Fitzgerald Reiterates Neutral Rating on Molina Healthcare (MOH)
-
Cantor Fitzgerald Reiterates Overweight Rating on UnitedHealth Group (UNH)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Elevance (ELV)
-
Cantor Fitzgerald Reiterates Neutral Rating on Centene (CNC)
-
Cantor Fitzgerald Reiterates Overweight Rating on CIGNA (CI)
-
Cantor Fitzgerald Reiterates Overweight Rating on Axsome Therapeutics (AXSM)
-
Cantor Fitzgerald Reiterates Overweight Rating on CoreWeave (CRWV)
-
Sharps Technology partners with BONK for Solana staking initiative
-
Sharps Technology and BONK Announce Staking Collaboration, Bridging Institutional Capital and Web3 Culture
-
Rocket Lab sets up $750 million stock offering program
-
Avidity Biosciences closes $690M stock offering

